000
| 01702nam 2200337za 4500 |
---|
001 | 9.859277 |
---|
003 | CaOODSP |
---|
005 | 20221107160221 |
---|
007 | cr ||||||||||| |
---|
008 | 180718s2018 onc o f000 0 eng d |
---|
022 | |z1925-0835 |
---|
040 | |aCaOODSP|beng |
---|
043 | |an-cn--- |
---|
086 | 1 |aH113-24/2018-21E-PDF|zH113-24/2018-21E |
---|
245 | 00|aMandipropamid |h[electronic resource]. |
---|
260 | |aOttawa : |bPest Management Regulatory Agency, Health Canada, |c2018. |
---|
300 | |a3 p. |
---|
490 | 1 |aProposed maximum residue limit, |x1925-0843 ; |vPMRL2018-21 |
---|
500 | |aIssued also in French under title: Mandipropamide. |
---|
500 | |aCover title. |
---|
500 | |a"12 July 2018." |
---|
520 | |a"Under the authority of the Pest Control Products Act, Health Canada’s Pest ManagementRegulatory Agency (PMRA) has concluded that the registration of the new end-use product Orondis™ Ultra Fungicide on various commodities containing technical grade mandipropamid and oxathiapiprolin is acceptable. The evaluation of this mandipropamid application indicated that the end-use product has value and the human health and environmental risks associated with the new uses are acceptable"--P. 1. |
---|
530 | |aIssued also in print format. |
---|
692 | 07|2gccst|aFungicides |
---|
692 | 07|2gccst|aCertification |
---|
692 | 07|2gccst|aToxicology |
---|
710 | 1 |aCanada. |bHealth Canada. |
---|
710 | 1 |aCanada. |bPest Management Regulatory Agency. |
---|
775 | 08|tMandipropamide |w(CaOODSP)9.859279 |
---|
830 | #0|aProposed maximum residue limit,|x1925-0843 ; |vPMRL2018-21.|w(CaOODSP)9.505147 |
---|
856 | 40|qPDF|s168 KB|uhttps://publications.gc.ca/collections/collection_2018/sc-hc/h113-24/H113-24-2018-21-eng.pdf |
---|